Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in Man
KCa2负调控剂AP30663的作用机制:一种正在研发用于治疗人类心房颤动的新型化合物
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2020.00610
Bentzen, Bo Hjorth; Bomholtz, Sofia Hammami; Simó-Vicens, Rafel; Folkersen, Lasse; Abildgaard, Lea; Speerschneider, Tobias; Muthukumarasamy, Kalai Mangai; Edvardsson, Nils; Sørensen, Ulrik S; Grunnet, Morten; Diness, Jonas Goldin